Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sue Ping Thang

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Nuclear Medicine Communications|February 25, 2011
Differentiating suspected nasopharyngeal infection from carcinoma using dual-tracer and multiple time-point technetium-99m sestamibi and white blood cell SPECT/CT imagingAndrew Eik Hock Tan, Sue Ping Thang, Ajit Kumar Padhy
Journal of Breast Cancer|October 17, 2014
Postmastectomy/Axillary Node Dissection Chyloma: The Additional Value of SPECT/CT LymphoscintigraphySue Ping Thang, Aaron Kian Ti Tong, David Chee Eng Ng
Seminars in Musculoskeletal Radiology|April 10, 2014
SPECT/CT in musculoskeletal infectionsSue Ping Thang, Aaron Kian Ti Tong, Winnie Wing Chuen Lam, et al.
Endocrine|March 1, 2020
Recombinant human thyrotropin versus thyroid hormone withdrawal in an Asian populationCharlene Yu Lin Tang, Sue Ping Thang, Sumbul Zaheer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 21, 2017
Correction to: Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysisSue Ping Thang, Mei Sim Lung, Grace Kong, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 13, 2017
Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysisSue Ping Thang, Mei Sim Lung, Grace Kong, et al.
American Journal of Infection Control|June 14, 2011
Clinical characteristics and outcomes of hospitalized patients with 2009 H1N1 influenza in a large acute care tertiary hospital, SingaporeYin Maw Hsann, Sue Ping Thang, Zakir-Hussain Abdul Salam, et al.
Annals of Nuclear Medicine|December 23, 2015
A descriptive analysis of remnant activity during (90)Y resin microspheres radioembolization of hepatic tumors: technical factors and dosimetric implicationsLidia Sancho Rodríguez, Sue Ping Thang, HuiHua Li, et al.
Asia-Pacific Journal of Clinical Oncology|April 23, 2025
Prognostic [<sup>68</sup>Ga]Ga-PSMA-11 PET Biomarkers for [<sup>177</sup>Lu]Lu-PSMA Radioligand Therapy in Metastatic Castrate-Resistant Prostate Cancer (Asian Population Study)Nicola Xin Yi Koh, Wei Ming Chua, Winnie Wing-Chuen Lam, et al.
European Urology Oncology|August 15, 2019
Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for <sup>177</sup>Lu-labelled PSMA Radioligand TherapySue Ping Thang, John Violet, Shahneen Sandhu, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Nuclear Medicine Communications|February 25, 2011
Differentiating suspected nasopharyngeal infection from carcinoma using dual-tracer and multiple time-point technetium-99m sestamibi and white blood cell SPECT/CT imagingAndrew Eik Hock Tan, Sue Ping Thang, Ajit Kumar Padhy
Journal of Breast Cancer|October 17, 2014
Postmastectomy/Axillary Node Dissection Chyloma: The Additional Value of SPECT/CT LymphoscintigraphySue Ping Thang, Aaron Kian Ti Tong, David Chee Eng Ng
Seminars in Musculoskeletal Radiology|April 10, 2014
SPECT/CT in musculoskeletal infectionsSue Ping Thang, Aaron Kian Ti Tong, Winnie Wing Chuen Lam, et al.
Endocrine|March 1, 2020
Recombinant human thyrotropin versus thyroid hormone withdrawal in an Asian populationCharlene Yu Lin Tang, Sue Ping Thang, Sumbul Zaheer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 21, 2017
Correction to: Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysisSue Ping Thang, Mei Sim Lung, Grace Kong, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 13, 2017
Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysisSue Ping Thang, Mei Sim Lung, Grace Kong, et al.
American Journal of Infection Control|June 14, 2011
Clinical characteristics and outcomes of hospitalized patients with 2009 H1N1 influenza in a large acute care tertiary hospital, SingaporeYin Maw Hsann, Sue Ping Thang, Zakir-Hussain Abdul Salam, et al.
Annals of Nuclear Medicine|December 23, 2015
A descriptive analysis of remnant activity during (90)Y resin microspheres radioembolization of hepatic tumors: technical factors and dosimetric implicationsLidia Sancho Rodríguez, Sue Ping Thang, HuiHua Li, et al.
Asia-Pacific Journal of Clinical Oncology|April 23, 2025
Prognostic [<sup>68</sup>Ga]Ga-PSMA-11 PET Biomarkers for [<sup>177</sup>Lu]Lu-PSMA Radioligand Therapy in Metastatic Castrate-Resistant Prostate Cancer (Asian Population Study)Nicola Xin Yi Koh, Wei Ming Chua, Winnie Wing-Chuen Lam, et al.
European Urology Oncology|August 15, 2019
Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for <sup>177</sup>Lu-labelled PSMA Radioligand TherapySue Ping Thang, John Violet, Shahneen Sandhu, et al.
Pageof 3